Health

5 facts about Ensemble Health Partners’ IPO plans

On Tuesday, financial cycle outsourcing company Ensemble Health Partners revealed new details of its planned initial public offering.

Here are five things to know about a company’s IPO plans.

1. Ensemble Health Partners, a Cincinnati-based company that health systems, hospitals and medical groups use to outsource revenue cycle management, filed for an IPO in September. After it goes public, the company plans to list its Class A common shares on the Nasdaq Global Select Market under the ticker “ENSB”.

2. Ensemble Health Partners said on Tuesday that it will launch a roadshow for an IPO, where executives tell investors about the company. They plan to offer 29.5 million Class A common shares with the option for underwriters to purchase up to 4.425 million additional Class A common shares.

3. The IPO price for Class A common stock is expected to be between $ 19 and $ 22 per share, according to Ensemble Health Partners. This means the company could raise up to $ 746.35 million in an IPO. Form S-1 this Ensemble Health Partners filed with the Securities and Exchange Commission on Tuesday.

4.Since 2019, Ensemble Health Partners, which was acquired by Bon Secours Mercy Health in 2016, is owned by the private equity firm Golden Gate Capital. Cincinnati-based Bon Secours Mercy Health sold 51% of Ensemble Health Partners to Golden Gate Capital in 2019, but remained a minority owner and client of the company.

Golden Gate Capital and Bon Secours Mercy Health will continue to exert “significant influence” on Ensemble Health Partners, according to the S-1 filing, “including overseeing decisions requiring shareholder approval,” as both companies will be responsible for the majority of the company’s voting power.

5. According to the data collected Digital health, business and technology… Of the four companies that went public in the third quarter of 2021, two completed an IPO and two went public through mergers with specialized acquisition companies.


Source link

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button